AI assistant
Sending…
Spero Therapeutics, Inc. — Director's Dealing 2021
Oct 14, 2021
34087_dirs_2021-10-14_fac74e02-5830-421d-9eb4-0ba6c98c7904.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Spero Therapeutics, Inc. (SPRO)
CIK: 0001701108
Period of Report: 2021-10-11
Reporting Person: Tregoning Kathleen (Director)
More from Spero Therapeutics, Inc.
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Jan 30
Regulatory Filings
2025
Dec 19
Regulatory Filings
2025
Nov 13